» Articles » PMID: 8649988

Repression by a Differentiation-specific Factor of the Human Cytomegalovirus Enhancer

Overview
Specialty Biochemistry
Date 1996 May 1
PMID 8649988
Citations 43
Authors
Affiliations
Soon will be listed here.
Abstract

We detected a novel nuclear protein, MRF, that binds to multiple sites on the modulator which is located upstream of the human cytomegalovirus major immediate early gene enhancer. The expression of MRF is differentiation specific; the DNA binding activity is present in nuclear extracts from undifferentiated Tera-2 and THP-1 cells, but significantly reduced after these cells are induced to differentiate. In undifferentiated cells the enhancer activity is repressed by the modulator and upon differentiation the enhancer becomes active. Competitive binding assays demonstrate that MRF requires the presence of multiple A+T stretches for binding to DNA, rather than binding to a specific DNA sequence. Mutations of these stretches in the modulator reduce the binding activity of MRF, as well as the repressing activity on the enhancer. These results suggest that MRF may act as a repressor of enhancer function. We propose that MRF binds over the entire modulator and exerts repressor activity.

Citing Articles

regulates fatty acid metabolism and proliferation at the Pre-B cell stage during B cell development.

Chalise J, Ehsani A, Lemecha M, Hung Y, Zhang G, Larson G Front Immunol. 2023; 14:1170475.

PMID: 37483604 PMC: 10360657. DOI: 10.3389/fimmu.2023.1170475.


The emerging role of Arid5a in cancer: A new target for tumors.

Nyati K, Kishimoto T Genes Dis. 2023; 10(3):813-824.

PMID: 37396543 PMC: 10308073. DOI: 10.1016/j.gendis.2021.12.012.


NFκB and Cyclic AMP Response Element Sites Mediate the Valproic Acid and UL138 Responsiveness of the Human Cytomegalovirus Major Immediate Early Enhancer and Promoter.

Albright E, Walter R, Saffert R, Kalejta R J Virol. 2023; 97(3):e0002923.

PMID: 36856444 PMC: 10062163. DOI: 10.1128/jvi.00029-23.


Association of two ARID5B gene variant single nucleotide polymorphisms with acute lymphoblastic leukemia in the Egyptian population.

Gamaleldin M, Imbaby S Asian Pac J Cancer Prev. 2023; 24(1):337-343.

PMID: 36708585 PMC: 10152858. DOI: 10.31557/APJCP.2023.24.1.337.


Recent Advances in the Role of Arid5a in Immune Diseases and Cancer.

Nyati K, Kishimoto T Front Immunol. 2022; 12:827611.

PMID: 35126382 PMC: 8809363. DOI: 10.3389/fimmu.2021.827611.


References
1.
Hermiston T, Malone C, Stinski M . Human cytomegalovirus immediate-early two protein region involved in negative regulation of the major immediate-early promoter. J Virol. 1990; 64(7):3532-6. PMC: 249624. DOI: 10.1128/JVI.64.7.3532-3536.1990. View

2.
Nelson J, Gnann Jr J, Ghazal P . Regulation and tissue-specific expression of human cytomegalovirus. Curr Top Microbiol Immunol. 1990; 154:75-100. DOI: 10.1007/978-3-642-74980-3_4. View

3.
Kothari S, Baillie J, Sissons J, Sinclair J . The 21bp repeat element of the human cytomegalovirus major immediate early enhancer is a negative regulator of gene expression in undifferentiated cells. Nucleic Acids Res. 1991; 19(8):1767-71. PMC: 328102. DOI: 10.1093/nar/19.8.1767. View

4.
Shi Y, Seto E, Chang L, Shenk T . Transcriptional repression by YY1, a human GLI-Krüppel-related protein, and relief of repression by adenovirus E1A protein. Cell. 1991; 67(2):377-88. DOI: 10.1016/0092-8674(91)90189-6. View

5.
Park K, Atchison M . Isolation of a candidate repressor/activator, NF-E1 (YY-1, delta), that binds to the immunoglobulin kappa 3' enhancer and the immunoglobulin heavy-chain mu E1 site. Proc Natl Acad Sci U S A. 1991; 88(21):9804-8. PMC: 52809. DOI: 10.1073/pnas.88.21.9804. View